The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The present study is intended to investigate the safety and efficacy of the patients with
confirmed advanced pancreatic cancer after treating with the combination of raltitrexed for
injection and nab-paclitaxel.